Join us for a conversation about the latest research from Tass Lab, which is designed to impact the course of diseases like Parkinson’s, stroke and tinnitus, with the possibility of influencing numerous other diseases. Their technology appears to induce long-lasting relief with stimulation that is only delivered for a few hours on an intermittent or regular basis.
About our speaker: Dr. Peter Tass investigates and develops neuromodulation techniques for understanding and treating neurologic conditions such as Parkinson’s disease, epilepsy, dysfunction following stroke and tinnitus. He creates invasive and non-invasive therapeutic procedures by means of comprehensive computational neuroscience studies and advanced data analysis techniques. The computational neuroscience studies guide experiments that use clinical electrophysiology measures, such as high density EEG recordings and MRI imaging, and various outcome measures. He has pioneered a neuromodulation approach based on thorough computational modelling that employs dynamic self-organization, plasticity and other neuromodulation principles to produce sustained effects after stimulation. To investigate stimulation effects and disease-related brain activity, he focuses on the development of stimulation methods that cause a sustained neural desynchronization by an unlearning of abnormal synaptic interactions. He also performs and contributes to pre-clinical and clinical research in related areas. — This event is part of PCLA’s “Let’s Talk Parkinson’s” series of live online events. Special thanks to our program sponsors Abbott, Boston Scientific, Kyowa Kirin, Medtronic, and Supernus for making this series possible. Medtronic supports the scientific exchange of the Let’s Talk series but is not involved in selecting the speaker or the content and does not control whether the materials conform to FDA approved or cleared indications for pertinent Medtronic therapies. Learn more about PCLA at www.pcla.org.